nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR1—epilepsy syndrome	0.594	1	CbGaD
Nabilone—Dronabinol—CNR1—epilepsy syndrome	0.00291	0.546	CrCbGaD
Nabilone—CNR1—telencephalon—epilepsy syndrome	0.00272	0.192	CbGeAlD
Nabilone—CNR2—head—epilepsy syndrome	0.00244	0.172	CbGeAlD
Nabilone—CNR2—nervous system—epilepsy syndrome	0.00231	0.163	CbGeAlD
Nabilone—CNR2—central nervous system—epilepsy syndrome	0.00222	0.157	CbGeAlD
Nabilone—CNR2—brain—epilepsy syndrome	0.00176	0.124	CbGeAlD
Nabilone—CNR1—cerebellum—epilepsy syndrome	0.00151	0.107	CbGeAlD
Nabilone—CNR1—brain—epilepsy syndrome	0.00123	0.0865	CbGeAlD
Nabilone—Dronabinol—ABCG2—epilepsy syndrome	0.0011	0.206	CrCbGaD
Nabilone—Dronabinol—CYP2C19—epilepsy syndrome	0.000865	0.162	CrCbGaD
Nabilone—Dronabinol—ABCB1—epilepsy syndrome	0.000458	0.0858	CrCbGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL12—epilepsy syndrome	8.15e-05	0.000632	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CNR1—epilepsy syndrome	8e-05	0.00062	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCR3—epilepsy syndrome	8e-05	0.00062	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PLCB1—epilepsy syndrome	7.97e-05	0.000618	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	7.96e-05	0.000617	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PGF—epilepsy syndrome	7.89e-05	0.000612	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRM8—epilepsy syndrome	7.89e-05	0.000612	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCR2—epilepsy syndrome	7.87e-05	0.00061	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—SST—epilepsy syndrome	7.87e-05	0.00061	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HRH3—epilepsy syndrome	7.82e-05	0.000606	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—HTR7—epilepsy syndrome	7.81e-05	0.000605	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—NPY—epilepsy syndrome	7.8e-05	0.000604	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	7.79e-05	0.000604	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCR5—epilepsy syndrome	7.76e-05	0.000601	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—POMC—epilepsy syndrome	7.73e-05	0.000599	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRA2A—epilepsy syndrome	7.7e-05	0.000597	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—OPRM1—epilepsy syndrome	7.69e-05	0.000596	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRM2—epilepsy syndrome	7.68e-05	0.000596	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—HTR2A—epilepsy syndrome	7.59e-05	0.000589	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL2—epilepsy syndrome	7.56e-05	0.000586	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—OPRD1—epilepsy syndrome	7.53e-05	0.000584	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNAO1—epilepsy syndrome	7.53e-05	0.000584	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CRH—epilepsy syndrome	7.52e-05	0.000583	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—OXT—epilepsy syndrome	7.52e-05	0.000583	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	7.52e-05	0.000583	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT3—epilepsy syndrome	7.44e-05	0.000577	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL12—epilepsy syndrome	7.4e-05	0.000574	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—BDKRB2—epilepsy syndrome	7.4e-05	0.000574	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CNR1—epilepsy syndrome	7.27e-05	0.000563	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCR3—epilepsy syndrome	7.27e-05	0.000563	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PLCB1—epilepsy syndrome	7.24e-05	0.000561	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CHRM1—epilepsy syndrome	7.22e-05	0.00056	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDYN—epilepsy syndrome	7.22e-05	0.00056	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRM1—epilepsy syndrome	7.22e-05	0.00056	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCR7—epilepsy syndrome	7.22e-05	0.00056	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGT—epilepsy syndrome	7.2e-05	0.000558	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HTR7—epilepsy syndrome	7.09e-05	0.00055	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—NPY—epilepsy syndrome	7.08e-05	0.000549	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SSTR3—epilepsy syndrome	6.95e-05	0.000539	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HBEGF—epilepsy syndrome	6.88e-05	0.000534	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CRH—epilepsy syndrome	6.83e-05	0.00053	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—OXT—epilepsy syndrome	6.83e-05	0.00053	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL3—epilepsy syndrome	6.83e-05	0.00053	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL2—epilepsy syndrome	6.83e-05	0.00053	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—SST—epilepsy syndrome	6.8e-05	0.000527	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCR2—epilepsy syndrome	6.8e-05	0.000527	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	6.8e-05	0.000527	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CDC42—epilepsy syndrome	6.79e-05	0.000526	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GAL—epilepsy syndrome	6.79e-05	0.000526	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GFAP—epilepsy syndrome	6.79e-05	0.000526	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT3—epilepsy syndrome	6.76e-05	0.000524	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP2—epilepsy syndrome	6.71e-05	0.00052	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CHRM3—epilepsy syndrome	6.71e-05	0.00052	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRM5—epilepsy syndrome	6.71e-05	0.00052	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NPY2R—epilepsy syndrome	6.66e-05	0.000516	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	6.66e-05	0.000516	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR9—epilepsy syndrome	6.66e-05	0.000516	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SSTR1—epilepsy syndrome	6.66e-05	0.000516	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR8—epilepsy syndrome	6.66e-05	0.000516	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	6.66e-05	0.000516	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AVP—epilepsy syndrome	6.57e-05	0.000509	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRM3—epilepsy syndrome	6.53e-05	0.000506	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRM4—epilepsy syndrome	6.53e-05	0.000506	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CX3CR1—epilepsy syndrome	6.43e-05	0.000499	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DUSP4—epilepsy syndrome	6.41e-05	0.000497	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SSTR2—epilepsy syndrome	6.41e-05	0.000497	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	6.4e-05	0.000496	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	6.4e-05	0.000496	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CX3CL1—epilepsy syndrome	6.31e-05	0.000489	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CHRM2—epilepsy syndrome	6.31e-05	0.000489	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BDKRB1—epilepsy syndrome	6.31e-05	0.000489	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	6.26e-05	0.000485	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRM8—epilepsy syndrome	6.19e-05	0.00048	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PGF—epilepsy syndrome	6.19e-05	0.00048	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCR2—epilepsy syndrome	6.18e-05	0.000479	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SST—epilepsy syndrome	6.18e-05	0.000479	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CDC42—epilepsy syndrome	6.16e-05	0.000478	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GABBR1—epilepsy syndrome	6.14e-05	0.000476	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—HTR7—epilepsy syndrome	6.13e-05	0.000475	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—POMC—epilepsy syndrome	6.06e-05	0.00047	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	6.05e-05	0.000469	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AVP—epilepsy syndrome	5.97e-05	0.000463	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—AKT1—epilepsy syndrome	5.94e-05	0.00046	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL2—epilepsy syndrome	5.93e-05	0.00046	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—OPRD1—epilepsy syndrome	5.91e-05	0.000458	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GNAO1—epilepsy syndrome	5.91e-05	0.000458	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HRH3—epilepsy syndrome	5.88e-05	0.000456	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT3—epilepsy syndrome	5.84e-05	0.000453	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	5.81e-05	0.00045	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL12—epilepsy syndrome	5.81e-05	0.00045	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—OPRM1—epilepsy syndrome	5.79e-05	0.000449	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PLCB1—epilepsy syndrome	5.68e-05	0.00044	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CHRM1—epilepsy syndrome	5.66e-05	0.000439	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRM1—epilepsy syndrome	5.66e-05	0.000439	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDYN—epilepsy syndrome	5.66e-05	0.000439	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR7—epilepsy syndrome	5.66e-05	0.000439	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCR5—epilepsy syndrome	5.59e-05	0.000433	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HTR7—epilepsy syndrome	5.56e-05	0.000431	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCR3—epilepsy syndrome	5.47e-05	0.000424	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.47e-05	0.000424	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HBEGF—epilepsy syndrome	5.4e-05	0.000419	CbGpPWpGaD
Nabilone—Hallucination—Topiramate—epilepsy syndrome	5.35e-05	0.000207	CcSEcCtD
Nabilone—Tachycardia—Valproic Acid—epilepsy syndrome	5.34e-05	0.000207	CcSEcCtD
Nabilone—Diarrhoea—Zonisamide—epilepsy syndrome	5.34e-05	0.000207	CcSEcCtD
Nabilone—Pharyngitis—Topiramate—epilepsy syndrome	5.33e-05	0.000207	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ATP2A2—epilepsy syndrome	5.33e-05	0.000413	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NPY—epilepsy syndrome	5.33e-05	0.000413	CbGpPWpGaD
Nabilone—Loss of consciousness—Pregabalin—epilepsy syndrome	5.33e-05	0.000207	CcSEcCtD
Nabilone—Asthenia—Oxcarbazepine—epilepsy syndrome	5.33e-05	0.000207	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CDC42—epilepsy syndrome	5.33e-05	0.000413	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GAL—epilepsy syndrome	5.33e-05	0.000413	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GFAP—epilepsy syndrome	5.33e-05	0.000413	CbGpPWpGaD
Nabilone—Pruritus—Clonazepam—epilepsy syndrome	5.32e-05	0.000206	CcSEcCtD
Nabilone—Vomiting—Vigabatrin—epilepsy syndrome	5.32e-05	0.000206	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AKT3—epilepsy syndrome	5.3e-05	0.000411	CbGpPWpGaD
Nabilone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.29e-05	0.000205	CcSEcCtD
Nabilone—Cough—Pregabalin—epilepsy syndrome	5.29e-05	0.000205	CcSEcCtD
Nabilone—Pruritus—Phenytoin—epilepsy syndrome	5.28e-05	0.000205	CcSEcCtD
Nabilone—Nausea—Levetiracetam—epilepsy syndrome	5.28e-05	0.000205	CcSEcCtD
Nabilone—Rash—Vigabatrin—epilepsy syndrome	5.27e-05	0.000205	CcSEcCtD
Nabilone—Dizziness—Felbamate—epilepsy syndrome	5.27e-05	0.000204	CcSEcCtD
Nabilone—Dermatitis—Vigabatrin—epilepsy syndrome	5.27e-05	0.000204	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GRM5—epilepsy syndrome	5.27e-05	0.000408	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CHRM3—epilepsy syndrome	5.27e-05	0.000408	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP2—epilepsy syndrome	5.27e-05	0.000408	CbGpPWpGaD
Nabilone—Pruritus—Oxcarbazepine—epilepsy syndrome	5.26e-05	0.000204	CcSEcCtD
Nabilone—Convulsion—Pregabalin—epilepsy syndrome	5.25e-05	0.000204	CcSEcCtD
Nabilone—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.25e-05	0.000204	CcSEcCtD
Nabilone—Vision blurred—Gabapentin—epilepsy syndrome	5.24e-05	0.000203	CcSEcCtD
Nabilone—Headache—Vigabatrin—epilepsy syndrome	5.24e-05	0.000203	CcSEcCtD
Nabilone—Hypertension—Pregabalin—epilepsy syndrome	5.24e-05	0.000203	CcSEcCtD
Nabilone—Vomiting—Diazepam—epilepsy syndrome	5.24e-05	0.000203	CcSEcCtD
Nabilone—Anorexia—Valproic Acid—epilepsy syndrome	5.22e-05	0.000202	CcSEcCtD
Nabilone—Tremor—Gabapentin—epilepsy syndrome	5.21e-05	0.000202	CcSEcCtD
Nabilone—Rash—Diazepam—epilepsy syndrome	5.19e-05	0.000201	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—AGT—epilepsy syndrome	5.19e-05	0.000402	CbGpPWpGaD
Nabilone—Dermatitis—Diazepam—epilepsy syndrome	5.19e-05	0.000201	CcSEcCtD
Nabilone—Visual impairment—Topiramate—epilepsy syndrome	5.18e-05	0.000201	CcSEcCtD
Nabilone—Arthralgia—Pregabalin—epilepsy syndrome	5.16e-05	0.0002	CcSEcCtD
Nabilone—Myalgia—Pregabalin—epilepsy syndrome	5.16e-05	0.0002	CcSEcCtD
Nabilone—Chest pain—Pregabalin—epilepsy syndrome	5.16e-05	0.0002	CcSEcCtD
Nabilone—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.16e-05	0.0002	CcSEcCtD
Nabilone—Dizziness—Zonisamide—epilepsy syndrome	5.16e-05	0.0002	CcSEcCtD
Nabilone—Headache—Diazepam—epilepsy syndrome	5.16e-05	0.0002	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—AVP—epilepsy syndrome	5.16e-05	0.0004	CbGpPWpGaD
Nabilone—Anxiety—Pregabalin—epilepsy syndrome	5.15e-05	0.0002	CcSEcCtD
Nabilone—Diarrhoea—Clonazepam—epilepsy syndrome	5.14e-05	0.0002	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HSPB1—epilepsy syndrome	5.14e-05	0.000399	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL3—epilepsy syndrome	5.14e-05	0.000399	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—OXT—epilepsy syndrome	5.14e-05	0.000399	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CRH—epilepsy syndrome	5.14e-05	0.000399	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL2—epilepsy syndrome	5.14e-05	0.000399	CbGpPWpGaD
Nabilone—Anaemia—Gabapentin—epilepsy syndrome	5.14e-05	0.000199	CcSEcCtD
Nabilone—Hypotension—Valproic Acid—epilepsy syndrome	5.12e-05	0.000198	CcSEcCtD
Nabilone—Asthenia—Carbamazepine—epilepsy syndrome	5.11e-05	0.000198	CcSEcCtD
Nabilone—Agitation—Gabapentin—epilepsy syndrome	5.11e-05	0.000198	CcSEcCtD
Nabilone—Diarrhoea—Phenytoin—epilepsy syndrome	5.11e-05	0.000198	CcSEcCtD
Nabilone—Discomfort—Pregabalin—epilepsy syndrome	5.1e-05	0.000198	CcSEcCtD
Nabilone—Nausea—Fosphenytoin—epilepsy syndrome	5.1e-05	0.000198	CcSEcCtD
Nabilone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.08e-05	0.000197	CcSEcCtD
Nabilone—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.08e-05	0.000197	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CCR5—epilepsy syndrome	5.07e-05	0.000393	CbGpPWpGaD
Nabilone—Vomiting—Felbamate—epilepsy syndrome	5.07e-05	0.000197	CcSEcCtD
Nabilone—Dry mouth—Pregabalin—epilepsy syndrome	5.05e-05	0.000196	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CX3CR1—epilepsy syndrome	5.05e-05	0.000391	CbGpPWpGaD
Nabilone—Pruritus—Carbamazepine—epilepsy syndrome	5.04e-05	0.000196	CcSEcCtD
Nabilone—Rash—Felbamate—epilepsy syndrome	5.03e-05	0.000195	CcSEcCtD
Nabilone—Eye disorder—Topiramate—epilepsy syndrome	5.02e-05	0.000195	CcSEcCtD
Nabilone—Dermatitis—Felbamate—epilepsy syndrome	5.02e-05	0.000195	CcSEcCtD
Nabilone—Malaise—Gabapentin—epilepsy syndrome	5.01e-05	0.000195	CcSEcCtD
Nabilone—Tinnitus—Topiramate—epilepsy syndrome	5.01e-05	0.000194	CcSEcCtD
Nabilone—Vertigo—Gabapentin—epilepsy syndrome	5e-05	0.000194	CcSEcCtD
Nabilone—Headache—Felbamate—epilepsy syndrome	4.99e-05	0.000194	CcSEcCtD
Nabilone—Confusional state—Pregabalin—epilepsy syndrome	4.99e-05	0.000194	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.99e-05	0.000193	CcSEcCtD
Nabilone—Flushing—Topiramate—epilepsy syndrome	4.99e-05	0.000193	CcSEcCtD
Nabilone—Syncope—Gabapentin—epilepsy syndrome	4.99e-05	0.000193	CcSEcCtD
Nabilone—Leukopenia—Gabapentin—epilepsy syndrome	4.98e-05	0.000193	CcSEcCtD
Nabilone—Dizziness—Clonazepam—epilepsy syndrome	4.97e-05	0.000193	CcSEcCtD
Nabilone—Nausea—Vigabatrin—epilepsy syndrome	4.97e-05	0.000193	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—HTR2A—epilepsy syndrome	4.96e-05	0.000385	CbGpPWpGaD
Nabilone—Vomiting—Zonisamide—epilepsy syndrome	4.96e-05	0.000192	CcSEcCtD
Nabilone—Insomnia—Valproic Acid—epilepsy syndrome	4.95e-05	0.000192	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CHRM2—epilepsy syndrome	4.95e-05	0.000384	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BDKRB1—epilepsy syndrome	4.95e-05	0.000384	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CX3CL1—epilepsy syndrome	4.95e-05	0.000384	CbGpPWpGaD
Nabilone—Asthenia—Lamotrigine—epilepsy syndrome	4.94e-05	0.000192	CcSEcCtD
Nabilone—Dizziness—Phenytoin—epilepsy syndrome	4.94e-05	0.000192	CcSEcCtD
Nabilone—Rash—Zonisamide—epilepsy syndrome	4.92e-05	0.000191	CcSEcCtD
Nabilone—Infection—Pregabalin—epilepsy syndrome	4.92e-05	0.000191	CcSEcCtD
Nabilone—Paraesthesia—Valproic Acid—epilepsy syndrome	4.92e-05	0.000191	CcSEcCtD
Nabilone—Palpitations—Gabapentin—epilepsy syndrome	4.91e-05	0.000191	CcSEcCtD
Nabilone—Dermatitis—Zonisamide—epilepsy syndrome	4.91e-05	0.000191	CcSEcCtD
Nabilone—Dizziness—Oxcarbazepine—epilepsy syndrome	4.91e-05	0.000191	CcSEcCtD
Nabilone—Nausea—Diazepam—epilepsy syndrome	4.89e-05	0.00019	CcSEcCtD
Nabilone—Loss of consciousness—Gabapentin—epilepsy syndrome	4.89e-05	0.00019	CcSEcCtD
Nabilone—Headache—Zonisamide—epilepsy syndrome	4.89e-05	0.00019	CcSEcCtD
Nabilone—Dyspnoea—Valproic Acid—epilepsy syndrome	4.88e-05	0.000189	CcSEcCtD
Nabilone—Diarrhoea—Carbamazepine—epilepsy syndrome	4.88e-05	0.000189	CcSEcCtD
Nabilone—Pruritus—Lamotrigine—epilepsy syndrome	4.87e-05	0.000189	CcSEcCtD
Nabilone—Shock—Pregabalin—epilepsy syndrome	4.87e-05	0.000189	CcSEcCtD
Nabilone—Somnolence—Valproic Acid—epilepsy syndrome	4.87e-05	0.000189	CcSEcCtD
Nabilone—Cough—Gabapentin—epilepsy syndrome	4.85e-05	0.000188	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CDC42—epilepsy syndrome	4.84e-05	0.000375	CbGpPWpGaD
Nabilone—Tachycardia—Pregabalin—epilepsy syndrome	4.83e-05	0.000187	CcSEcCtD
Nabilone—Chills—Topiramate—epilepsy syndrome	4.82e-05	0.000187	CcSEcCtD
Nabilone—Dyspepsia—Valproic Acid—epilepsy syndrome	4.82e-05	0.000187	CcSEcCtD
Nabilone—Convulsion—Gabapentin—epilepsy syndrome	4.82e-05	0.000187	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GABBR1—epilepsy syndrome	4.82e-05	0.000373	CbGpPWpGaD
Nabilone—Hypertension—Gabapentin—epilepsy syndrome	4.8e-05	0.000186	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.79e-05	0.000372	CbGpPWpGaD
Nabilone—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.78e-05	0.000186	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TSC1—epilepsy syndrome	4.78e-05	0.000371	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTK2B—epilepsy syndrome	4.78e-05	0.000371	CbGpPWpGaD
Nabilone—Vomiting—Clonazepam—epilepsy syndrome	4.78e-05	0.000185	CcSEcCtD
Nabilone—Decreased appetite—Valproic Acid—epilepsy syndrome	4.76e-05	0.000185	CcSEcCtD
Nabilone—Vomiting—Phenytoin—epilepsy syndrome	4.75e-05	0.000184	CcSEcCtD
Nabilone—Rash—Clonazepam—epilepsy syndrome	4.74e-05	0.000184	CcSEcCtD
Nabilone—Dermatitis—Clonazepam—epilepsy syndrome	4.74e-05	0.000184	CcSEcCtD
Nabilone—Chest pain—Gabapentin—epilepsy syndrome	4.73e-05	0.000184	CcSEcCtD
Nabilone—Arthralgia—Gabapentin—epilepsy syndrome	4.73e-05	0.000184	CcSEcCtD
Nabilone—Myalgia—Gabapentin—epilepsy syndrome	4.73e-05	0.000184	CcSEcCtD
Nabilone—Nausea—Felbamate—epilepsy syndrome	4.73e-05	0.000184	CcSEcCtD
Nabilone—Vomiting—Oxcarbazepine—epilepsy syndrome	4.72e-05	0.000183	CcSEcCtD
Nabilone—Fatigue—Valproic Acid—epilepsy syndrome	4.72e-05	0.000183	CcSEcCtD
Nabilone—Anxiety—Gabapentin—epilepsy syndrome	4.72e-05	0.000183	CcSEcCtD
Nabilone—Anorexia—Pregabalin—epilepsy syndrome	4.72e-05	0.000183	CcSEcCtD
Nabilone—Dizziness—Carbamazepine—epilepsy syndrome	4.71e-05	0.000183	CcSEcCtD
Nabilone—Diarrhoea—Lamotrigine—epilepsy syndrome	4.71e-05	0.000183	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—AGT—epilepsy syndrome	4.71e-05	0.000365	CbGpPWpGaD
Nabilone—Headache—Clonazepam—epilepsy syndrome	4.71e-05	0.000183	CcSEcCtD
Nabilone—Rash—Phenytoin—epilepsy syndrome	4.71e-05	0.000183	CcSEcCtD
Nabilone—Dermatitis—Phenytoin—epilepsy syndrome	4.7e-05	0.000182	CcSEcCtD
Nabilone—Rash—Oxcarbazepine—epilepsy syndrome	4.68e-05	0.000182	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AVP—epilepsy syndrome	4.68e-05	0.000363	CbGpPWpGaD
Nabilone—Constipation—Valproic Acid—epilepsy syndrome	4.68e-05	0.000182	CcSEcCtD
Nabilone—Pain—Valproic Acid—epilepsy syndrome	4.68e-05	0.000182	CcSEcCtD
Nabilone—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.68e-05	0.000182	CcSEcCtD
Nabilone—Headache—Phenytoin—epilepsy syndrome	4.68e-05	0.000181	CcSEcCtD
Nabilone—Discomfort—Gabapentin—epilepsy syndrome	4.68e-05	0.000181	CcSEcCtD
Nabilone—Headache—Oxcarbazepine—epilepsy syndrome	4.65e-05	0.000181	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCR2—epilepsy syndrome	4.65e-05	0.000361	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NTRK2—epilepsy syndrome	4.65e-05	0.000361	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SST—epilepsy syndrome	4.65e-05	0.000361	CbGpPWpGaD
Nabilone—Nausea—Zonisamide—epilepsy syndrome	4.63e-05	0.00018	CcSEcCtD
Nabilone—Dry mouth—Gabapentin—epilepsy syndrome	4.63e-05	0.00018	CcSEcCtD
Nabilone—Hypotension—Pregabalin—epilepsy syndrome	4.63e-05	0.000179	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HRH3—epilepsy syndrome	4.62e-05	0.000358	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DUSP6—epilepsy syndrome	4.61e-05	0.000357	CbGpPWpGaD
Nabilone—Tension—Topiramate—epilepsy syndrome	4.59e-05	0.000178	CcSEcCtD
Nabilone—Confusional state—Gabapentin—epilepsy syndrome	4.58e-05	0.000177	CcSEcCtD
Nabilone—Dizziness—Lamotrigine—epilepsy syndrome	4.56e-05	0.000177	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.55e-05	0.000353	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—OPRM1—epilepsy syndrome	4.55e-05	0.000352	CbGpPWpGaD
Nabilone—Nervousness—Topiramate—epilepsy syndrome	4.54e-05	0.000176	CcSEcCtD
Nabilone—Vomiting—Carbamazepine—epilepsy syndrome	4.53e-05	0.000176	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PLAT—epilepsy syndrome	4.53e-05	0.000351	CbGpPWpGaD
Nabilone—Back pain—Topiramate—epilepsy syndrome	4.53e-05	0.000176	CcSEcCtD
Nabilone—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.51e-05	0.000175	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.51e-05	0.000175	CcSEcCtD
Nabilone—Infection—Gabapentin—epilepsy syndrome	4.51e-05	0.000175	CcSEcCtD
Nabilone—Rash—Carbamazepine—epilepsy syndrome	4.49e-05	0.000174	CcSEcCtD
Nabilone—Dermatitis—Carbamazepine—epilepsy syndrome	4.49e-05	0.000174	CcSEcCtD
Nabilone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.48e-05	0.000174	CcSEcCtD
Nabilone—Insomnia—Pregabalin—epilepsy syndrome	4.48e-05	0.000174	CcSEcCtD
Nabilone—Nausea—Clonazepam—epilepsy syndrome	4.47e-05	0.000173	CcSEcCtD
Nabilone—Headache—Carbamazepine—epilepsy syndrome	4.47e-05	0.000173	CcSEcCtD
Nabilone—Shock—Gabapentin—epilepsy syndrome	4.47e-05	0.000173	CcSEcCtD
Nabilone—Paraesthesia—Pregabalin—epilepsy syndrome	4.44e-05	0.000172	CcSEcCtD
Nabilone—Nausea—Phenytoin—epilepsy syndrome	4.44e-05	0.000172	CcSEcCtD
Nabilone—Tachycardia—Gabapentin—epilepsy syndrome	4.43e-05	0.000172	CcSEcCtD
Nabilone—Dyspnoea—Pregabalin—epilepsy syndrome	4.41e-05	0.000171	CcSEcCtD
Nabilone—Nausea—Oxcarbazepine—epilepsy syndrome	4.41e-05	0.000171	CcSEcCtD
Nabilone—Vision blurred—Topiramate—epilepsy syndrome	4.41e-05	0.000171	CcSEcCtD
Nabilone—Somnolence—Pregabalin—epilepsy syndrome	4.4e-05	0.000171	CcSEcCtD
Nabilone—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.39e-05	0.00017	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CCR5—epilepsy syndrome	4.38e-05	0.00034	CbGpPWpGaD
Nabilone—Tremor—Topiramate—epilepsy syndrome	4.38e-05	0.00017	CcSEcCtD
Nabilone—Vomiting—Lamotrigine—epilepsy syndrome	4.38e-05	0.00017	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CXCL12—epilepsy syndrome	4.37e-05	0.000339	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.37e-05	0.000339	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—POMC—epilepsy syndrome	4.37e-05	0.000339	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.35e-05	0.000337	CbGpPWpGaD
Nabilone—Rash—Lamotrigine—epilepsy syndrome	4.34e-05	0.000168	CcSEcCtD
Nabilone—Ill-defined disorder—Topiramate—epilepsy syndrome	4.34e-05	0.000168	CcSEcCtD
Nabilone—Dermatitis—Lamotrigine—epilepsy syndrome	4.34e-05	0.000168	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.34e-05	0.000336	CbGpPWpGaD
Nabilone—Body temperature increased—Valproic Acid—epilepsy syndrome	4.33e-05	0.000168	CcSEcCtD
Nabilone—Abdominal pain—Valproic Acid—epilepsy syndrome	4.33e-05	0.000168	CcSEcCtD
Nabilone—Anorexia—Gabapentin—epilepsy syndrome	4.33e-05	0.000168	CcSEcCtD
Nabilone—Anaemia—Topiramate—epilepsy syndrome	4.32e-05	0.000168	CcSEcCtD
Nabilone—Headache—Lamotrigine—epilepsy syndrome	4.32e-05	0.000167	CcSEcCtD
Nabilone—Decreased appetite—Pregabalin—epilepsy syndrome	4.3e-05	0.000167	CcSEcCtD
Nabilone—Agitation—Topiramate—epilepsy syndrome	4.3e-05	0.000167	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CNR1—epilepsy syndrome	4.29e-05	0.000333	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUNB—epilepsy syndrome	4.29e-05	0.000333	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR3—epilepsy syndrome	4.29e-05	0.000333	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	4.29e-05	0.000333	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLCB1—epilepsy syndrome	4.28e-05	0.000332	CbGpPWpGaD
Nabilone—Fatigue—Pregabalin—epilepsy syndrome	4.27e-05	0.000166	CcSEcCtD
Nabilone—Hypotension—Gabapentin—epilepsy syndrome	4.24e-05	0.000164	CcSEcCtD
Nabilone—Nausea—Carbamazepine—epilepsy syndrome	4.23e-05	0.000164	CcSEcCtD
Nabilone—Constipation—Pregabalin—epilepsy syndrome	4.23e-05	0.000164	CcSEcCtD
Nabilone—Pain—Pregabalin—epilepsy syndrome	4.23e-05	0.000164	CcSEcCtD
Nabilone—Malaise—Topiramate—epilepsy syndrome	4.22e-05	0.000164	CcSEcCtD
Nabilone—Vertigo—Topiramate—epilepsy syndrome	4.2e-05	0.000163	CcSEcCtD
Nabilone—Syncope—Topiramate—epilepsy syndrome	4.2e-05	0.000163	CcSEcCtD
Nabilone—Leukopenia—Topiramate—epilepsy syndrome	4.19e-05	0.000162	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HTR7—epilepsy syndrome	4.19e-05	0.000325	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NPY—epilepsy syndrome	4.18e-05	0.000324	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ATP2A2—epilepsy syndrome	4.18e-05	0.000324	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.14e-05	0.00016	CcSEcCtD
Nabilone—Palpitations—Topiramate—epilepsy syndrome	4.13e-05	0.00016	CcSEcCtD
Nabilone—Loss of consciousness—Topiramate—epilepsy syndrome	4.11e-05	0.000159	CcSEcCtD
Nabilone—Insomnia—Gabapentin—epilepsy syndrome	4.11e-05	0.000159	CcSEcCtD
Nabilone—Nausea—Lamotrigine—epilepsy syndrome	4.09e-05	0.000159	CcSEcCtD
Nabilone—Cough—Topiramate—epilepsy syndrome	4.08e-05	0.000158	CcSEcCtD
Nabilone—Feeling abnormal—Pregabalin—epilepsy syndrome	4.08e-05	0.000158	CcSEcCtD
Nabilone—Paraesthesia—Gabapentin—epilepsy syndrome	4.08e-05	0.000158	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—AGT—epilepsy syndrome	4.07e-05	0.000316	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HBEGF—epilepsy syndrome	4.07e-05	0.000315	CbGpPWpGaD
Nabilone—Convulsion—Topiramate—epilepsy syndrome	4.05e-05	0.000157	CcSEcCtD
Nabilone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.05e-05	0.000157	CcSEcCtD
Nabilone—Dyspnoea—Gabapentin—epilepsy syndrome	4.05e-05	0.000157	CcSEcCtD
Nabilone—Hypertension—Topiramate—epilepsy syndrome	4.04e-05	0.000157	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HSPB1—epilepsy syndrome	4.04e-05	0.000313	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL3—epilepsy syndrome	4.04e-05	0.000313	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL2—epilepsy syndrome	4.04e-05	0.000313	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—OXT—epilepsy syndrome	4.04e-05	0.000313	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CRH—epilepsy syndrome	4.04e-05	0.000313	CbGpPWpGaD
Nabilone—Somnolence—Gabapentin—epilepsy syndrome	4.03e-05	0.000156	CcSEcCtD
Nabilone—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.03e-05	0.000156	CcSEcCtD
Nabilone—Dyspepsia—Gabapentin—epilepsy syndrome	4e-05	0.000155	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—AKT3—epilepsy syndrome	3.99e-05	0.000309	CbGpPWpGaD
Nabilone—Myalgia—Topiramate—epilepsy syndrome	3.98e-05	0.000154	CcSEcCtD
Nabilone—Arthralgia—Topiramate—epilepsy syndrome	3.98e-05	0.000154	CcSEcCtD
Nabilone—Chest pain—Topiramate—epilepsy syndrome	3.98e-05	0.000154	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CCR5—epilepsy syndrome	3.98e-05	0.000309	CbGpPWpGaD
Nabilone—Anxiety—Topiramate—epilepsy syndrome	3.97e-05	0.000154	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—POMC—epilepsy syndrome	3.97e-05	0.000307	CbGpPWpGaD
Nabilone—Decreased appetite—Gabapentin—epilepsy syndrome	3.95e-05	0.000153	CcSEcCtD
Nabilone—Discomfort—Topiramate—epilepsy syndrome	3.94e-05	0.000153	CcSEcCtD
Nabilone—Asthenia—Valproic Acid—epilepsy syndrome	3.93e-05	0.000152	CcSEcCtD
Nabilone—Fatigue—Gabapentin—epilepsy syndrome	3.91e-05	0.000152	CcSEcCtD
Nabilone—Body temperature increased—Pregabalin—epilepsy syndrome	3.91e-05	0.000152	CcSEcCtD
Nabilone—Abdominal pain—Pregabalin—epilepsy syndrome	3.91e-05	0.000152	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADAM10—epilepsy syndrome	3.9e-05	0.000302	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HTR2A—epilepsy syndrome	3.9e-05	0.000302	CbGpPWpGaD
Nabilone—Dry mouth—Topiramate—epilepsy syndrome	3.9e-05	0.000151	CcSEcCtD
Nabilone—Constipation—Gabapentin—epilepsy syndrome	3.88e-05	0.000151	CcSEcCtD
Nabilone—Pain—Gabapentin—epilepsy syndrome	3.88e-05	0.000151	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CCL2—epilepsy syndrome	3.88e-05	0.000301	CbGpPWpGaD
Nabilone—Pruritus—Valproic Acid—epilepsy syndrome	3.87e-05	0.00015	CcSEcCtD
Nabilone—Confusional state—Topiramate—epilepsy syndrome	3.85e-05	0.000149	CcSEcCtD
Nabilone—Infection—Topiramate—epilepsy syndrome	3.79e-05	0.000147	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.76e-05	0.000292	CbGpPWpGaD
Nabilone—Shock—Topiramate—epilepsy syndrome	3.76e-05	0.000146	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PTK2B—epilepsy syndrome	3.75e-05	0.000291	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TSC1—epilepsy syndrome	3.75e-05	0.000291	CbGpPWpGaD
Nabilone—Diarrhoea—Valproic Acid—epilepsy syndrome	3.75e-05	0.000145	CcSEcCtD
Nabilone—Feeling abnormal—Gabapentin—epilepsy syndrome	3.74e-05	0.000145	CcSEcCtD
Nabilone—Tachycardia—Topiramate—epilepsy syndrome	3.73e-05	0.000145	CcSEcCtD
Nabilone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.71e-05	0.000144	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AGT—epilepsy syndrome	3.7e-05	0.000287	CbGpPWpGaD
Nabilone—Hyperhidrosis—Topiramate—epilepsy syndrome	3.69e-05	0.000143	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—S100B—epilepsy syndrome	3.69e-05	0.000286	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SST—epilepsy syndrome	3.65e-05	0.000283	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NTRK2—epilepsy syndrome	3.65e-05	0.000283	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR2—epilepsy syndrome	3.65e-05	0.000283	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SOCS3—epilepsy syndrome	3.65e-05	0.000283	CbGpPWpGaD
Nabilone—Hypersensitivity—Pregabalin—epilepsy syndrome	3.65e-05	0.000141	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CDC42—epilepsy syndrome	3.64e-05	0.000282	CbGpPWpGaD
Nabilone—Anorexia—Topiramate—epilepsy syndrome	3.64e-05	0.000141	CcSEcCtD
Nabilone—Dizziness—Valproic Acid—epilepsy syndrome	3.62e-05	0.00014	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—DUSP6—epilepsy syndrome	3.62e-05	0.00028	CbGpPWpGaD
Nabilone—Abdominal pain—Gabapentin—epilepsy syndrome	3.59e-05	0.000139	CcSEcCtD
Nabilone—Body temperature increased—Gabapentin—epilepsy syndrome	3.59e-05	0.000139	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—ADRA2A—epilepsy syndrome	3.57e-05	0.000277	CbGpPWpGaD
Nabilone—Hypotension—Topiramate—epilepsy syndrome	3.57e-05	0.000138	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PLAT—epilepsy syndrome	3.56e-05	0.000276	CbGpPWpGaD
Nabilone—Asthenia—Pregabalin—epilepsy syndrome	3.55e-05	0.000138	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—AVP—epilepsy syndrome	3.52e-05	0.000273	CbGpPWpGaD
Nabilone—Pruritus—Pregabalin—epilepsy syndrome	3.5e-05	0.000136	CcSEcCtD
Nabilone—Vomiting—Valproic Acid—epilepsy syndrome	3.48e-05	0.000135	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.48e-05	0.000135	CcSEcCtD
Nabilone—Insomnia—Topiramate—epilepsy syndrome	3.45e-05	0.000134	CcSEcCtD
Nabilone—Rash—Valproic Acid—epilepsy syndrome	3.45e-05	0.000134	CcSEcCtD
Nabilone—Dermatitis—Valproic Acid—epilepsy syndrome	3.45e-05	0.000134	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—BDKRB2—epilepsy syndrome	3.43e-05	0.000266	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL12—epilepsy syndrome	3.43e-05	0.000266	CbGpPWpGaD
Nabilone—Headache—Valproic Acid—epilepsy syndrome	3.43e-05	0.000133	CcSEcCtD
Nabilone—Paraesthesia—Topiramate—epilepsy syndrome	3.43e-05	0.000133	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—POMC—epilepsy syndrome	3.43e-05	0.000266	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PRKCB—epilepsy syndrome	3.42e-05	0.000265	CbGpPWpGaD
Nabilone—Dyspnoea—Topiramate—epilepsy syndrome	3.4e-05	0.000132	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—IL6ST—epilepsy syndrome	3.4e-05	0.000264	CbGpPWpGaD
Nabilone—Somnolence—Topiramate—epilepsy syndrome	3.39e-05	0.000132	CcSEcCtD
Nabilone—Diarrhoea—Pregabalin—epilepsy syndrome	3.39e-05	0.000131	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—JUNB—epilepsy syndrome	3.37e-05	0.000261	CbGpPWpGaD
Nabilone—Dyspepsia—Topiramate—epilepsy syndrome	3.36e-05	0.00013	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PLCB1—epilepsy syndrome	3.36e-05	0.00026	CbGpPWpGaD
Nabilone—Hypersensitivity—Gabapentin—epilepsy syndrome	3.34e-05	0.00013	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HES1—epilepsy syndrome	3.33e-05	0.000258	CbGpPWpGaD
Nabilone—Decreased appetite—Topiramate—epilepsy syndrome	3.32e-05	0.000129	CcSEcCtD
Nabilone—Fatigue—Topiramate—epilepsy syndrome	3.29e-05	0.000128	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HTR7—epilepsy syndrome	3.29e-05	0.000255	CbGpPWpGaD
Nabilone—Dizziness—Pregabalin—epilepsy syndrome	3.27e-05	0.000127	CcSEcCtD
Nabilone—Pain—Topiramate—epilepsy syndrome	3.27e-05	0.000127	CcSEcCtD
Nabilone—Constipation—Topiramate—epilepsy syndrome	3.27e-05	0.000127	CcSEcCtD
Nabilone—Asthenia—Gabapentin—epilepsy syndrome	3.26e-05	0.000126	CcSEcCtD
Nabilone—Nausea—Valproic Acid—epilepsy syndrome	3.25e-05	0.000126	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FYN—epilepsy syndrome	3.24e-05	0.000251	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—H2AFX—epilepsy syndrome	3.23e-05	0.00025	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MEF2C—epilepsy syndrome	3.22e-05	0.00025	CbGpPWpGaD
Nabilone—Pruritus—Gabapentin—epilepsy syndrome	3.21e-05	0.000125	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HBEGF—epilepsy syndrome	3.19e-05	0.000247	CbGpPWpGaD
Nabilone—Vomiting—Pregabalin—epilepsy syndrome	3.15e-05	0.000122	CcSEcCtD
Nabilone—Feeling abnormal—Topiramate—epilepsy syndrome	3.15e-05	0.000122	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—AKT3—epilepsy syndrome	3.13e-05	0.000243	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.12e-05	0.000121	CcSEcCtD
Nabilone—Rash—Pregabalin—epilepsy syndrome	3.12e-05	0.000121	CcSEcCtD
Nabilone—Dermatitis—Pregabalin—epilepsy syndrome	3.12e-05	0.000121	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.12e-05	0.000242	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—POMC—epilepsy syndrome	3.11e-05	0.000241	CbGpPWpGaD
Nabilone—Diarrhoea—Gabapentin—epilepsy syndrome	3.11e-05	0.00012	CcSEcCtD
Nabilone—Headache—Pregabalin—epilepsy syndrome	3.1e-05	0.00012	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NGF—epilepsy syndrome	3.08e-05	0.000239	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADAM10—epilepsy syndrome	3.06e-05	0.000237	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL2—epilepsy syndrome	3.04e-05	0.000236	CbGpPWpGaD
Nabilone—Body temperature increased—Topiramate—epilepsy syndrome	3.02e-05	0.000117	CcSEcCtD
Nabilone—Abdominal pain—Topiramate—epilepsy syndrome	3.02e-05	0.000117	CcSEcCtD
Nabilone—Dizziness—Gabapentin—epilepsy syndrome	3e-05	0.000116	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCR5—epilepsy syndrome	3e-05	0.000232	CbGpPWpGaD
Nabilone—Nausea—Pregabalin—epilepsy syndrome	2.94e-05	0.000114	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HTR2A—epilepsy syndrome	2.93e-05	0.000227	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—S100B—epilepsy syndrome	2.89e-05	0.000224	CbGpPWpGaD
Nabilone—Vomiting—Gabapentin—epilepsy syndrome	2.89e-05	0.000112	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SOCS3—epilepsy syndrome	2.86e-05	0.000222	CbGpPWpGaD
Nabilone—Rash—Gabapentin—epilepsy syndrome	2.86e-05	0.000111	CcSEcCtD
Nabilone—Dermatitis—Gabapentin—epilepsy syndrome	2.86e-05	0.000111	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CDC42—epilepsy syndrome	2.86e-05	0.000221	CbGpPWpGaD
Nabilone—Headache—Gabapentin—epilepsy syndrome	2.84e-05	0.00011	CcSEcCtD
Nabilone—Hypersensitivity—Topiramate—epilepsy syndrome	2.81e-05	0.000109	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TSC2—epilepsy syndrome	2.79e-05	0.000216	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGT—epilepsy syndrome	2.78e-05	0.000216	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AVP—epilepsy syndrome	2.77e-05	0.000214	CbGpPWpGaD
Nabilone—Asthenia—Topiramate—epilepsy syndrome	2.74e-05	0.000106	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—APOE—epilepsy syndrome	2.73e-05	0.000211	CbGpPWpGaD
Nabilone—Pruritus—Topiramate—epilepsy syndrome	2.7e-05	0.000105	CcSEcCtD
Nabilone—Nausea—Gabapentin—epilepsy syndrome	2.7e-05	0.000105	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—KDR—epilepsy syndrome	2.67e-05	0.000207	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HES1—epilepsy syndrome	2.62e-05	0.000203	CbGpPWpGaD
Nabilone—Diarrhoea—Topiramate—epilepsy syndrome	2.61e-05	0.000101	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PRKCB—epilepsy syndrome	2.57e-05	0.000199	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6ST—epilepsy syndrome	2.56e-05	0.000199	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FYN—epilepsy syndrome	2.54e-05	0.000197	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—H2AFX—epilepsy syndrome	2.53e-05	0.000196	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MEF2C—epilepsy syndrome	2.53e-05	0.000196	CbGpPWpGaD
Nabilone—Dizziness—Topiramate—epilepsy syndrome	2.53e-05	9.79e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.45e-05	0.00019	CbGpPWpGaD
Nabilone—Vomiting—Topiramate—epilepsy syndrome	2.43e-05	9.42e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NGF—epilepsy syndrome	2.42e-05	0.000187	CbGpPWpGaD
Nabilone—Rash—Topiramate—epilepsy syndrome	2.41e-05	9.34e-05	CcSEcCtD
Nabilone—Dermatitis—Topiramate—epilepsy syndrome	2.41e-05	9.33e-05	CcSEcCtD
Nabilone—Headache—Topiramate—epilepsy syndrome	2.39e-05	9.28e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCR5—epilepsy syndrome	2.35e-05	0.000182	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—POMC—epilepsy syndrome	2.34e-05	0.000182	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HTR2A—epilepsy syndrome	2.3e-05	0.000178	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL2—epilepsy syndrome	2.29e-05	0.000178	CbGpPWpGaD
Nabilone—Nausea—Topiramate—epilepsy syndrome	2.27e-05	8.8e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TSC2—epilepsy syndrome	2.19e-05	0.000169	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGT—epilepsy syndrome	2.18e-05	0.000169	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOE—epilepsy syndrome	2.14e-05	0.000166	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KDR—epilepsy syndrome	2.1e-05	0.000163	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGF2—epilepsy syndrome	2.07e-05	0.000161	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKCB—epilepsy syndrome	2.02e-05	0.000156	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6ST—epilepsy syndrome	2.01e-05	0.000156	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RELA—epilepsy syndrome	1.92e-05	0.000149	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MTOR—epilepsy syndrome	1.89e-05	0.000146	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—POMC—epilepsy syndrome	1.84e-05	0.000142	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL2—epilepsy syndrome	1.8e-05	0.000139	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.75e-05	0.000136	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—epilepsy syndrome	1.73e-05	0.000134	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUN—epilepsy syndrome	1.68e-05	0.000131	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—epilepsy syndrome	1.64e-05	0.000127	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF2—epilepsy syndrome	1.63e-05	0.000126	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—epilepsy syndrome	1.59e-05	0.000123	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SRC—epilepsy syndrome	1.51e-05	0.000117	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RELA—epilepsy syndrome	1.51e-05	0.000117	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MTOR—epilepsy syndrome	1.48e-05	0.000115	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—epilepsy syndrome	1.47e-05	0.000114	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.37e-05	0.000106	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—epilepsy syndrome	1.36e-05	0.000106	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JUN—epilepsy syndrome	1.32e-05	0.000102	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—epilepsy syndrome	1.29e-05	9.97e-05	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—epilepsy syndrome	1.25e-05	9.67e-05	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SRC—epilepsy syndrome	1.19e-05	9.19e-05	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—epilepsy syndrome	1.15e-05	8.95e-05	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—epilepsy syndrome	9.39e-06	7.28e-05	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—epilepsy syndrome	7.37e-06	5.71e-05	CbGpPWpGaD
